COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
Coeptis (Nasdaq: COEP) has announced a strategic partnership between its NexGenAI Affiliates Network and MarketLeverage, combining AI technology with performance-based marketing strategies. The collaboration connects NexGenAI's AI-powered platform with MarketLeverage's network of 5,500 advertisers and 55,000 publishers.
The partnership provides access to AI-driven campaign management, predictive analytics, and automated outreach capabilities. NexGenAI's platform enables affiliates to earn commissions through automated content distribution, social media sharing, and targeted email campaigns with real-time AI optimization.
The artificial intelligence marketing market is projected to grow from $27.83 billion in 2024 to $106.54 billion in 2029, with a CAGR of 31.6%. This partnership aims to enhance marketing efficiency, drive higher-quality traffic, and increase conversions through advanced automation and data-driven insights.
Coeptis (Nasdaq: COEP) ha annunciato una partnership strategica tra il suo NexGenAI Affiliates Network e MarketLeverage, unendo la tecnologia AI con strategie di marketing basate sulle performance. La collaborazione collega la piattaforma alimentata dall'AI di NexGenAI con la rete di 5.500 inserzionisti e 55.000 editori di MarketLeverage.
La partnership offre accesso alla gestione delle campagne guidata dall'AI, analisi predittive e capacità di outreach automatizzate. La piattaforma di NexGenAI consente agli affiliati di guadagnare commissioni attraverso la distribuzione automatizzata dei contenuti, la condivisione sui social media e campagne email mirate con ottimizzazione AI in tempo reale.
Il mercato del marketing basato sull'intelligenza artificiale è previsto crescere da 27,83 miliardi di dollari nel 2024 a 106,54 miliardi di dollari nel 2029, con un CAGR del 31,6%. Questa partnership mira a migliorare l'efficienza del marketing, generare traffico di alta qualità e aumentare le conversioni attraverso automazioni avanzate e approfondimenti basati sui dati.
Coeptis (Nasdaq: COEP) ha anunciado una asociación estratégica entre su NexGenAI Affiliates Network y MarketLeverage, combinando la tecnología de IA con estrategias de marketing basadas en el rendimiento. La colaboración conecta la plataforma impulsada por IA de NexGenAI con la red de 5,500 anunciantes y 55,000 editores de MarketLeverage.
La asociación proporciona acceso a la gestión de campañas impulsada por IA, análisis predictivos y capacidades de outreach automatizadas. La plataforma de NexGenAI permite a los afiliados ganar comisiones a través de la distribución automatizada de contenido, la compartición en redes sociales y campañas de correo electrónico dirigidas con optimización de IA en tiempo real.
Se espera que el mercado de marketing basado en inteligencia artificial crezca de 27.83 mil millones de dólares en 2024 a 106.54 mil millones de dólares en 2029, con una tasa de crecimiento anual compuesta (CAGR) del 31.6%. Esta asociación tiene como objetivo mejorar la eficiencia del marketing, generar tráfico de alta calidad y aumentar las conversiones a través de automatización avanzada e información basada en datos.
Coeptis (Nasdaq: COEP)는 NexGenAI Affiliates Network와 MarketLeverage 간의 전략적 파트너십을 발표했습니다. 이 파트너십은 AI 기술과 성과 기반 마케팅 전략을 결합한 것입니다. 협력은 NexGenAI의 AI 기반 플랫폼을 MarketLeverage의 5,500 광고주 및 55,000 퍼블리셔 네트워크와 연결합니다.
이 파트너십은 AI 기반 캠페인 관리, 예측 분석 및 자동화된 아울리치 기능에 대한 액세스를 제공합니다. NexGenAI의 플랫폼은 제휴사들이 자동화된 콘텐츠 배포, 소셜 미디어 공유 및 실시간 AI 최적화를 통한 타겟 이메일 캠페인으로 커미션을 벌 수 있도록 합니다.
인공지능 마케팅 시장은 2024년 278억 3천만 달러에서 2029년 1,065억 4천만 달러로 성장할 것으로 예상되며, 연평균 성장률(CAGR)은 31.6%입니다. 이 파트너십은 마케팅 효율성을 향상시키고, 더 높은 품질의 트래픽을 유도하며, 고급 자동화 및 데이터 기반 통찰력을 통해 전환율을 높이는 것을 목표로 합니다.
Coeptis (Nasdaq: COEP) a annoncé un partenariat stratégique entre son NexGenAI Affiliates Network et MarketLeverage, combinant la technologie IA avec des stratégies de marketing basées sur la performance. La collaboration relie la plateforme alimentée par l'IA de NexGenAI au réseau de 5 500 annonceurs et 55 000 éditeurs de MarketLeverage.
Le partenariat offre un accès à la gestion de campagne pilotée par l'IA, des analyses prédictives et des capacités d'approche automatisées. La plateforme de NexGenAI permet aux affiliés de gagner des commissions grâce à la distribution automatisée de contenu, au partage sur les réseaux sociaux et aux campagnes d'e-mails ciblés avec optimisation IA en temps réel.
Le marché du marketing basé sur l'intelligence artificielle devrait passer de 27,83 milliards de dollars en 2024 à 106,54 milliards de dollars en 2029, avec un taux de croissance annuel composé (CAGR) de 31,6 %. Ce partenariat vise à améliorer l'efficacité marketing, à générer un trafic de meilleure qualité et à augmenter les conversions grâce à une automatisation avancée et des insights basés sur les données.
Coeptis (Nasdaq: COEP) hat eine strategische Partnerschaft zwischen seinem NexGenAI Affiliates Network und MarketLeverage bekannt gegeben, die KI-Technologie mit leistungsbasierten Marketingstrategien kombiniert. Die Zusammenarbeit verbindet die KI-gesteuerte Plattform von NexGenAI mit dem Netzwerk von 5.500 Werbetreibenden und 55.000 Publishern von MarketLeverage.
Die Partnerschaft bietet Zugang zu KI-gesteuertem Kampagnenmanagement, prädiktiven Analysen und automatisierten Outreach-Funktionen. Die Plattform von NexGenAI ermöglicht es Affiliates, durch automatisierte Inhaltsverteilung, Social Media Sharing und gezielte E-Mail-Kampagnen mit Echtzeit-KI-Optimierung Provisionen zu verdienen.
Der Markt für Marketing auf Basis künstlicher Intelligenz wird voraussichtlich von 27,83 Milliarden Dollar im Jahr 2024 auf 106,54 Milliarden Dollar im Jahr 2029 wachsen, mit einer jährlichen Wachstumsrate (CAGR) von 31,6%. Diese Partnerschaft zielt darauf ab, die Marketingeffizienz zu verbessern, hochwertigen Traffic zu generieren und die Konversionen durch fortschrittliche Automatisierung und datengestützte Einblicke zu erhöhen.
- Access to MarketLeverage's extensive network of 5,500 advertisers and 55,000 publishers
- Entry into rapidly growing AI marketing market ($27.83B in 2024 to $106.54B in 2029)
- Integration of AI-driven automation tools expected to increase conversion rates and ROI
- None.
Insights
This strategic partnership marks a pivotal transformation for COEPTIS, signaling its aggressive expansion into the high-growth AI marketing sector. The collaboration with MarketLeverage provides three critical competitive advantages:
- Immediate scale through access to 5,500 advertisers and 55,000 publishers, eliminating the typical multi-year network building phase
- Integration of AI-driven automation tools that can significantly reduce operational costs while improving campaign performance
- Potential for recurring revenue streams through automated commission structures and platform fees
The timing is particularly strategic, as the AI marketing sector is experiencing exponential growth, projected to reach
However, investors should note several key considerations. The success of this venture hinges on effective integration of NexGenAI's technology with MarketLeverage's existing infrastructure. The affiliate marketing industry is highly competitive, with established players like Impact and CJ Affiliate dominating the space. COEPTIS's differentiation through AI automation could provide a compelling advantage, but execution and technology adoption rates among publishers will be important metrics to monitor.
The partnership also represents a significant pivot from COEPTIS's traditional biotech focus, suggesting a broader strategic transformation. While this diversification could open new revenue streams, it also introduces execution risks and potential resource allocation challenges that warrant careful monitoring.
This partnership gives COEPTIS access to AI-driven campaign management, predictive analytics, and automated outreach capabilities with MarketLeverage’s 5,500 advertisers and 55,000 publishers, creating one of the most expansive and effective affiliate networks in the industry
WEXFORD, Pa., Feb. 20, 2025 (GLOBE NEWSWIRE) -- COEPTIS, Inc. (Nasdaq: COEP) ("the Company" or "Coeptis"), a pioneering technology firm at the forefront of innovative biotechnology solutions, is thrilled to announce a partnership between COEPTIS’ NexGenAI Affiliates Network and MarketLeverage, a leading digital advertising firm and affiliate network. This collaboration aims to redefine affiliate marketing by integrating cutting-edge AI technology with performance-based strategies.
With MarketLeverage’s extensive industry expertise and NexGenAI Affiliates Network’s innovative AI-powered platform, this collaboration will empower affiliates, brands, and marketers with advanced automation, data-driven insights, and seamless campaign optimization. MarketLeverage currently works with 5,500 advertisers and 55,000 publishers, creating one of the most expansive and effective affiliate networks in the industry. This strategic partnership will drive high-quality traffic, increase conversions, and enhance overall marketing efficiency.
“This partnership marks a significant step in transforming digital marketing by integrating AI with performance-based strategies,” said Shane Hackett, CEO of MarketLeverage. “By combining our extensive network of advertisers and affiliates with NexGenAI’s automated tools, we will provide businesses with unprecedented opportunities to scale their marketing efforts. The future of affiliate marketing is in automation and AI-driven insights, and we are excited to lead this transformation.”
NexGenAI Affiliates Network, recently acquired by Coeptis Therapeutics Holdings Inc., has quickly established itself as a leader in AI-powered marketing automation. The platform enables affiliates to earn commissions through automated content distribution, social media sharing, and targeted email campaigns, leveraging AI to optimize performance in real-time.
“Our mission has always been to empower marketers with the latest AI-driven solutions,” said Dave Mehalick, CEO of Coeptis Therapeutics Holdings Inc. “Partnering with MarketLeverage will accelerate our reach and provide affiliates and brands with an unmatched ability to monetize digital content and drive engagement. With MarketLeverage’s vast network and our AI-powered tools, we are creating a new frontier in performance marketing.”
Through this collaboration, affiliates will gain access to an enhanced suite of tools, including AI-driven campaign management, predictive analytics, and automated outreach capabilities. Advertisers will benefit from increased visibility, higher conversion rates, and improved return on investment.
The partnership between MarketLeverage and NexGenAI Affiliates Network underscores a shared commitment to innovation and efficiency in the digital marketing space. As AI continues to shape the future of affiliate marketing, this alliance ensures that brands, affiliates, and publishers stay ahead of the curve. As COEPTIS has entered the artificial intelligence marketplace, the market size will grow from
For more information on this partnership and how it can benefit businesses and affiliates, visit https://www.marketleverage.com/ and https://nexgenaiaffiliates.io/.
About COEPTIS, Inc.
COEPTIS, Inc., together with its subsidiaries Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc., SNAP Biosciences, Inc., and Coeptis Technologies (collectively "Coeptis"), is a biopharmaceutical and technology company. The biopharmaceutical divisions focus on developing innovative cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its cutting-edge research and development efforts.
The Company's therapeutic portfolio is underscored by assets licensed from Deverra Therapeutics, which include an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. COEPTIS is also developing a universal, multi-antigen CAR technology licensed from the University of Pittsburgh (SNAP-CAR), alongside GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and distinguished medical researchers at the Karolinska Institute.
Building on its core competencies, COEPTIS has recently established a Technology Division, which focuses on enhancing operational capabilities through advanced technologies. This division features AI-powered marketing software and robotic process automation tools acquired from NexGenAI Solutions Group, designed to optimize business processes and improve overall efficiency.
Headquartered in Wexford, PA, COEPTIS is dedicated to advancing its mission within the regulatory framework set forth by the FDA, ensuring that all activities align with the highest standards of compliance and patient care. For more information on COEPTIS, visit https://coeptistx.com
About MarketLeverage
MarketLeverage is an award-winning digital advertising firm specializing in performance marketing and affiliate campaign management. With over two decades of experience, the company helps brands scale their digital presence through targeted lead generation and strategic partnerships. MarketLeverage has been recognized as an INC 100 Advertising Agency and among the Fortune 5000 Fastest Growing Private Companies. MarketLeverage currently works with 5,500 advertisers and 55,000 publishers to drive impactful marketing campaigns.
About NexGenAI Affiliates Network
NexGenAI Affiliates Network is a state-of-the-art AI-powered affiliate marketing platform designed to streamline marketing efforts through automation and advanced analytics. Owned by Coeptis Therapeutics Holdings Inc., NexGenAI Affiliates Network empowers individuals and businesses to optimize their affiliate campaigns and maximize revenue through AI-driven content distribution, automated email outreach, and social media integration.
Cautionary Note Regarding Forward-Looking Statements
This press release and statements of our management made in connection therewith contain or may contain "forward-looking statements" (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). Forward-looking statements include statements concerning our plans, objectives, goals, strategies, future events or performance, and underlying assumptions, and other statements that are other than statements of historical facts. When we use words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, we are making forward-looking statements. Forward-looking statements are not a guarantee of future performance and involve significant risks and uncertainties that may cause the actual results to differ materially and perhaps substantially from our expectations discussed in the forward-looking statements. Factors that may cause such differences include but are not limited to: (1) the inability to maintain the listing of the Company's securities on the Nasdaq Capital Market; (2) the inability to recognize the anticipated benefits of the Deverra licensed assets, which may be affected by, among other things, competition, the ability of the Company to grow and manage growth economically and hire and retain key employees; (3) the risks that the Company's products in development or the newly-licensed assets fail clinical trials or are not approved by the U.S. Food and Drug Administration or other applicable regulatory authorities; (4) costs related to ongoing asset development including the Deverra licensed assets and pursuing the contemplated asset development paths; (5) changes in applicable laws or regulations; (6) the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; and (7) the impact of the global COVID-19 pandemic on any of the foregoing risks and other risks and uncertainties identified in the Company's filings with the Securities and Exchange Commission (the "SEC"). The foregoing list of factors is not exclusive. All forward-looking statements are subject to significant uncertainties and risks including, but not limited, to those risks contained or to be contained in reports and other filings filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings made or to be made with the SEC, which are available for review at www.sec.gov. We undertake no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof unless required by applicable laws, regulations, or rules.
Contacts
IR@coeptistx.com
FAQ
What is the strategic partnership between Coeptis (COEP) and MarketLeverage?
How large is MarketLeverage's network that COEP now has access to?
What is the projected growth of the AI marketing market that COEP is entering?
What AI capabilities does the COEP-MarketLeverage partnership offer?
